Liufu Deng

9.6k citations

34 papers · 7.3k indexed · 4 hit papers · h-index 22

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Phagocytosis and Immune Regulation
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 28
- interferon and immune responses 15
- Immune Cell Function and Interaction 11
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 5
- Immune Response and Inflammation 3
Oncology 14
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 4

Co-authors: Yang‐Xin Fu Hua Liang Ralph R. Weichselbaum Byron Burnette Michael A. Beckett Thomas E. Darga Xuanming Yang Xiaona Huang
Journals: Immunity (6 papers)Cell Reports (3 papers)Clinical Cancer Research (2 papers)OncoImmunology (2 papers)The Journal of Cell Biology (1 paper)
Partner nations: China United States Thailand

In The Last Decade

Liufu Deng

32 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Radiotherapy and immunotherapy: a beneficial liaison? 2017 · 781 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Nature Reviews Clinical Oncology
2015 Nature Medicine
2014 Journal of Clinical Investigation
2014 Immunity

Peers

Countries citing papers authored by Liufu Deng

Since Specialization

Citations

This map shows the geographic impact of Liufu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liufu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liufu Deng more than expected).

Fields of papers citing papers by Liufu Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liufu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liufu Deng. The network helps show where Liufu Deng may publish in the future.

Co-authors

The 25 scholars most cited alongside Liufu Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liufu Deng Line = papers co-authored together Liufu Deng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ZBP1 pathway promotes tumor immunogenicity in the combination of anti-HER2 therapy and epigenetic therapy Cell Reports ·Qishan Wang, Zhihao Wu, Yuanqin Yang, Chao Yang, Huan Deng, Xingyue Zhou, Shuting Xu, Lingling Wu, Xiaochuan Hong, Xueni Yu, Lu Lu, Liufu Deng	2025	0
2	Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer? Cancer Biology and Medicine ·Lin Ma, Liufu Deng, Jianfeng Peng, Jinming Yu, Xiangjiao Meng	2024	6
3	TIM-3 inhibitors: a promising strategy for tumor immunotherapy Trends in Molecular Medicine ·Lu Lu, Liufu Deng	2024	7
4	Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy Cell Reports ·Xinran Wang, Lu Lu, Xiaochuan Hong, Lingling Wu, Chao Yang, You Wang, Wenwen Li, Yuanqin Yang, Dongqing Cao, Wen Di, Liufu Deng	2024	11
5	STING activation in platelets aggravates septic thrombosis by enhancing platelet activation and granule secretion Immunity ·Mina Yang, Haojie Jiang, Chen Ding, Lin Zhang, Nan Ding, Guoming Li, Fei Zhang, Jing Wang, Liufu Deng, Junling Liu, Yanyan Xu	2023	73
6	Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth Chemical Science ·Chunyong Ding, Mengyan Du, Zhihua Xiong, Xue Wang, Hongji Li, Ende He, Li Han, Yijing Dang, Qing Lü, Shicong Li, Ruoxuan Xiao, Zhiai Xu, Lili Jing, Liufu Deng, Xiyuan Wang, Meiyu Geng, Zuoquan Xie, Ao Zhang	2023	14
7	STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells Cell Reports ·Lu Lu, Chao Yang, Xingyue Zhou, Lingling Wu, Xiaochuan Hong, Wenwen Li, Xinran Wang, Yuanqin Yang, Dongqing Cao, Ao Zhang, Wen Di, Liufu Deng	2023	40
8	STING controls energy stress-induced autophagy and energy metabolism via STX17 The Journal of Cell Biology ·Yueguang Rong, Shen Zhang, Nilay Nandi, Zhe Wu, Linsen Li, Yang Liu, Yuehan Wei, Yuan Zhao, Weigang Yuan, Chuchu Zhou, Guanghua Xiao, Beth Levine, Nan Yan, Shan Mou, Liufu Deng, Zaiming Tang, Xiaoxia Liu, Helmut Krämer, Qing Zhong	2022	48
9	Mitotic SENP3 activation couples with cGAS signaling in tumor cells to stimulate anti-tumor immunity Cell Death and Disease ·Gaolei Hu, Yalan Chen, Xinyu Yang, Yang Wang, Jianli He, Tianshi Wang, Qiuju Fan, Liufu Deng, Jun Tu, Hongsheng Tan, Jinke Cheng	2022	5
10	Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity Immunity ·Chao Yang, Jingsi Jin, Yuanqin Yang, Hongxiang Sun, Lingling Wu, Mingyi Shen, Xiaochuan Hong, Wenwen Li, Lu Lu, Dongqing Cao, Xinran Wang, Jing Ping Sun, Youqiong Ye, Bing Su, Liufu Deng	2022	104
11	ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation Science Advances ·Yuanqin Yang, Meng Wu, Dongqing Cao, Chao Yang, Jingsi Jin, Lingling Wu, Xiaochuan Hong, Wenwen Li, Lu Lu, Jinmei Li, Xinran Wang, Xiangjiao Meng, Zhen Zhang, Jinke Cheng, Youqiong Ye, Hui Xiao, Jinming Yu, Liufu Deng	2021	128
12	P1.13-03 Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype Journal of Thoracic Oncology ·T. Ye, Liufu Deng, Shuman Wang, Junmiao Xiang, Y. Zhang, H. Hu, Y. Sun, Y. Li, Lijing Shen, L. Xie, Wen-bo Gu, Y. Zhao, Feiyu Fu, Wenxuan Peng, H. Chen, Ying-Hao Shen	2019	1
13	Host STING-dependent MDSC mobilization drives extrinsic radiation resistance Nature Communications ·Hua Liang, Liufu Deng, Yuzhu Hou, Xiangjiao Meng, Xiaona Huang, Enyu Rao, Wenxin Zheng, Helena J. Mauceri, Matthias Mack, Meng Xu, Yang-Xin Fu, Ralph R. Weichselbaum	2017	366
14	Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling Immunity ·Meng Xu, Pu Yang, Dali Han, Yaoyao Shi, Xuezhi Cao, Hua Liang, Xiang Chen, Xiao-Dong Li, Liufu Deng, Zhijian J. Chen, Ralph R. Weichselbaum, Yang-Xin Fu	2017	241
15	CD47 blockade triggers T cell–mediated destruction of immunogenic tumors Nature Medicine ·Xiaojuan Liu, Yang Pu, Kyle R. Cron, Liufu Deng, Justin Kline, William A. Frazier, Hairong Xu, Hua Peng, Yang‐Xin Fu, Meng Xu Hit paper breakdown →	2015	611
16	Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice Journal of Clinical Investigation ·Liufu Deng, Hua Liang, Byron Burnette, Michael A. Beckett, Thomas E. Darga, Ralph R. Weichselbaum, Yang‐Xin Fu Hit paper breakdown →	2014	1599
17	STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors Immunity ·Liufu Deng, Hua Liang, Meng Xu, Xuanming Yang, Byron Burnette, Ainhoa Arina, Xiao-Dong Li, Helena J. Mauceri, Michael A. Beckett, Thomas E. Darga, Xiaona Huang, Thomas F. Gajewski, Zhijian J. Chen, Yang‐Xin Fu, Ralph R. Weichselbaum Hit paper breakdown →	2014	1538
18	Induction of Innate Lymphoid Cell-Derived Interleukin-22 by the Transcription Factor STAT3 Mediates Protection against Intestinal Infection Immunity ·Xiaohuan Guo, Ju Qiu, Tony Tu, Xuanming Yang, Liufu Deng, Robert A. Anders, Liang Zhou, Yang‐Xin Fu	2014	212
19	Lymphotoxin regulates commensal responses to enable diet-induced obesity Nature Immunology ·Vaibhav Upadhyay, Valeriy Poroyko, Tae-Jin Kim, Suzanne Devkota, Sherry Fu, Donald Liu, Alexei V. Tumanov, Ekaterina P. Koroleva, Liufu Deng, Cathryn R. Nagler, Eugene B. Chang, Hong Tang, Yang‐Xin Fu	2012	108
20	The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity Cancer Cell ·SaeGwang Park, Zhujun Jiang, Eric D. Mortenson, Liufu Deng, Olga Radkevich-Brown, Xuanming Yang, Husain Sattar, Yang Wang, Nicholas K. Brown, Mark I. Greene, Yang Liu, Jie Tang, Shengdian Wang, Yang‐Xin Fu	2010	433

About Liufu Deng

Liufu Deng is a scholar working on Immunology, Oncology, Infectious Diseases, Cancer Research and Psychiatry and Mental health, having authored 34 papers that have together received 7.3k indexed citations. Recurring topics across this work include interferon and immune responses (15 papers), Immune Cell Function and Interaction (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (6 papers), Viral Infections and Vectors (5 papers), Immune cells in cancer (5 papers), CAR-T cell therapy research (4 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Immunology (4.5k citations), Oncology (4.0k citations), Cancer Research (554 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Infectious Diseases (573 citations). Liufu Deng has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yang‐Xin Fu, Hua Liang, Ralph R. Weichselbaum, Byron Burnette, Michael A. Beckett, Thomas E. Darga, Xuanming Yang, Xiaona Huang, Helena J. Mauceri and Meng Xu. Their work appears in journals such as Immunity, Cell Reports, Clinical Cancer Research, OncoImmunology and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact